MAPK3 and cancer: Gao et al. found that the sEV EphA2 from drug-resistant cancer cells activated the ERK1/2 signaling pathway by inducing reverse Ephrin signaling to stimulate aggressive phenotypic metastasis of drug-sensitive cancer cells and promote migration and invasion of breast cancer [89].